MOLEKULE CONSULTING, INC.
Molekule’s broad industry expertise and diverse client base is evidenced through repeat client engagement, successful intelligence development and delivery and measurable ROIs on key biopharmaceutical business objectives.
Biopharmaceutical consulting leveraging primary competitive intelligence as the cornerstone of Molekule Consulting’s portfolio of industry-specific consulting and service offerings.
CORE SERVICE OFFERINGS
Our portfolio of key consulting services spans a broad range of core offerings enabling Molekule’s client partners to intrinsically align consulting engagements for measurable success and to drive marked ROIs on biopharmaceutical business goals.
KEY THERAPY AREAS SERVED
Molekule’s Therapy Area Leadership (“TAL”) program mandates all FTE consulting staff maintain therapy area fluency and clinical, commercial, manufacturing and supply chain/logistics and regulatory excellence in therapeutic spaces where they are actively engaged.
Our client base continues to grow based upon repeat client engagement, client satisfaction and active client referrals. We serve numerous clients globally in the U.S., EU, LATAM, CEE/CIS, Middle East and APAC regions on an international scope and scale.
GLOBAL CLINICAL, COMMERCIAL & REGULATORY SOURCES
Molekule’s robust and growing organic source network spans > 20,000 contacts, globally. We foster persistent source development via active project engagement and regular attendance of global medical congresses and biopharmaceutical trade shows.
MOLEKULE CONSULTING, INC.
BY THE FACTS AND NUMBERS
MOLEKULE’S EMPLOYMENT QUALIFICATIONS
Employs intelligence industry experts, MDs, Ph.D.s, Pharm.D.s and experienced business professionals (MBAs)
• Global Headquarters
in Miami, Florida, USA
• Founded and Incorporated in 2012
• EU Headquarters in London, UK
• Incorporated in 2014
OUR STAFFING MODEL
Operates a diverse staffing model
Employs FTE subject matter experts and seasoned pharmaceutical & management consulting industry professionals
MOLEKULE & CLIENT PARTNERS
Continually devoted to client centricity and ongoing client communication
MOLEKULE & COMPETITIVE INTELLIGENCE
We leverage primary competitive intelligence as the fundamental basis of our insights and actionable recommendations to drive improved business results
OUR GLOBAL OPERATIONS
Principal ex-U.S. physical operations in the EU, CIS/ CEE, Asia-Pacific, LATAM and Israel
Our global footprint has “feet-on-the-street” and language fluency in 27 core geographies
MOLEKULE & ACTIONABILITY DELIVERED
Molekule drives excellence in biopharmaceutical consulting and competitive intelligence. We deliver actionability returns that are key to biopharmaceutical business goals
GLOBAL ORGANIZATIONAL OVERVIEW
Molekule is a specialist management consultancy exclusive to the biopharmaceutical and life sciences verticals. We employ MDs, PhDs, PharmaDs and MBAs with real-world biopharmaceutical industry, medical/academic and/or intelligence experience, delivering to our client partners best-in-class competitive insight and intelligence.
All Molekule consultants are dedicated to CI research and associated strategic management consulting, based upon a framework of primary CI research. Molekule is amenable and able to “block” human capital and hard resources in support of our client partners and client-Molekule project engagement.
Our use of freelancers and/or subcontractors is infrequent and depends on two (2) factors – 1. MSA or service agreements enabling the use thereof and, 2. an enlightened and significant project-level contribution to be made due to robust and deep subject matter or therapy area expertise of the non-FTE contractor.
real-time robust two-way communication and interaction with Molekule Consulting and the Molekule executive leadership team. We are here to support your efforts and our engagements reflect this with continuous communication and contact available.
actionable and strategic insight and intelligence asserting implications and recommendation to support our clients’ business.
an organic and growing global source network across commercial & marketing, clinical & medical, regulatory & technical affairs, and manufacturing and supply chain/logistics stakeholders. Molekule yields deep, actionable and robust primary competitive insights degrees beyond the Key intelligence topics and questions (“KIT/Qs”) set forth by our client partners, resulting in markedly improved outcomes on overall client biopharmaceutical business objectives.
simply providing competitive insights and analytics is inadequate – Molekule transcends the norm and provides additional relevant intelligence data that are meaningful to you and your organization, further elucidating the answers to your KIT/Qs.
all output and deliverables for you. We provide the option of either using the Molekule Consulting template, or your brand, franchise or corporate template of choice.
ENGAGING AND PARTNERING
with Molekule provides stunning intelligence and insight into the competitive dynamics of the biopharmaceutical world. Whether a clinical, commercial, regulatory, or manufacturing and supply chain/logistics competitive exercise, the overall impact and implications is a positive ROI yielding significant and applicable business results.
MOLEKULE CONSULTING IS COMMITTED
to providing the highest quality competitive intelligence materially impacting your seminal biopharmaceutical business objectives and benefiting your organization’s bottom line
WE PROVIDE PREMIUM SERVICES AND BRING ADDED VALUE TO YOU AND YOUR ORGANIZATION
As a specialty consulting firm focused specifically on the biopharmaceutical, medical device, and life sciences verticals, Molekule delivers high impact and actionable primary competitive intelligence solutions yielding significantly positive returns on your biopharmaceutical business objectives. Partnering with Molekule results in transformational changes to your overall bottom line.
Our client partners accurately invest and/or divest in in-line and developmental pipeline assets based upon Molekule’s accurate, timely, and informed primary competitive intelligence research.
Primary Competitive Intelligence
Market Intelligence & Analytics
Scientific & Commercial Biopharmaceutical Conference Coverage
Generics and Biosimilars Threat Assessments & Technical Evaluations
DAVID L. ALDERMAN
David founded Molekule Consulting with an ethos of strategic & actionable competitive insight combined with client centricity. He is responsible for numerous engagements with different scopes and objectives in the competitive intelligence and primary market research areas. Project scopes can range from pre-clinical through launch and life-cycle management (“LCM”) to support clients in clinical and commercial strategy development. His major therapy expertise is in oncology ophthalmology, cardiovascular, diabetes, autoimmune, and CNS. David attends many major medical congresses and scientific congresses globally.
Prior to founding Molekule, David held progressive roles in biopharmaceutical and market intelligence executive leadership, conducting business development, managing projects and personnel, as well as developing primary intelligence in support of client engagements. David has extensive experience developing clinical and marketing strategies for both pharmaceutical and biotechnology companies, leveraging his skills in intelligence needs identification, collection, analysis and dissemination.
David holds a B.S. in Biology from Trinity College in Hartford, CT, and a M.Sc. in Biomedical Science from Columbia University College of Physicians and Surgeons in New York, NY. Additionally, David pursued doctoral study in Genetic Research, Genomics and the Molecular Biology of Disease at Emory University School of Medicine in Atlanta, GA.
Dr. DANIEL PASCHELES
Daniel joined Molekule Consulting in early 2017 as Chief Executive Officer and has over 20 years of experience in building world-class global competitive intelligence. As manager of large CI teams, Daniel oversaw and led during his successful career in the biopharmaceutical industry hundreds of primary CI projects, competitive simulations and strategic planning sessions.
Prior to joining Molekule Consulting, Daniel was Vice President and Head of Global Competitive Intelligence at Merck & Co /MSD for the last 12 years. Before that he worked for Aventis and its predecessor company (Hoechst Marion Roussel, Marion Merrell Dow) for 14 years in various positions such as Global Head of CI, European Head of Sales and Marketing Administration, European Head of Strategic Planning and General Manager Switzerland.
Daniel studied Pharmacy at the Swiss Federal Institute of Technology (ETH) in Zurich, Switzerland. He received his Ph.D. in Pharmaceutical Technology from the same university. He did additional studies at the University of Kansas in Lawrence, Kansas. Daniel is Past-President and a current Board member of the Pharmaceutical Business Intelligence & Research Group (PBIRG). He is also a member of the Society of Competitive Intelligence Professionals (SCIP) and the Licensing Executive Society (LES). He is a well-known speaker/ chairman of International Conferences on Competitive Intelligence. He is a member of the Editorial Advisory Board member of the Pharmaceutical Executive magazine and publishes regularly in various trade magazines. Daniel is also Visiting Professor at the Rey Juan Carlos University in Madrid teaching a Master Class in CI.
Hezekiah Blake is a competitive intelligence functional expert with over 15 years of relevant experience. He has extensive management experience at Novartis, and Bayer having built teams and managed multi-millions in support of blockbuster assets.
Holding various global pharma roles and working across cultures while living in India, he is adept at building rapport and delivering value across culture and geography in the global, matrixed pharma environment. On the consulting side, Hezekiah has built, managed and delivered engagements against brand and franchise strategic imperatives. Typical projects include clinical assessments, competitive benchmarking, risk assessments, competitor opinion leader and publication heat-maps, strategic and tactical scenario planning workshops. Hezekiah’s therapeutic areas of expertise include Hemophilia, Virology, Immunology, Oncology, MS & the orphan disease space.
Prior to joining Molekule, at Bayer, Hezekiah was responsible for proactive CI defense including corporate security, formalizing partnership between legal and CI, develop and launch of an enterprise wide insight portal, and Insights lead of $2B+ franchise. Previously, Hezekiah served Novartis as a Function Head for the CI group. There he directly managed a team of 14 associates and transitioned the organization to a service-based delivery system.
Mr. Blake holds a Masters of Bioscience, Business of Bioscience focus, from The Keck Graduate Institute of Applied Life Sciences, a member of the Claremont Colleges and a Bachelor of Science in Biology from The University of California San Diego. Hezekiah served as the student body president for his graduating Masters class.